4CPS-085 Assessment of the direct-acting antivirals used to treat the hepatitis c virus genotype 4 infection in a tertiary hospital

BackgroundHepatitis C is a serious disease with high prevalence, being the leading cause of liver transplantation. The development of well-tolerated and highly-effective direct acting antivirals (DAAs) for hepatitis C virus (HCV) has dramatically changed the therapeutic landscapePurposeAssessing of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2018-03, Vol.25 (Suppl 1), p.A81-A81
Hauptverfasser:	Valencia, JC del Río, Torres, L Villalobos, Diez, R Asensi, Castillo, I Muñoz
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Antiviral drugs Genotype & phenotype Hepatitis Hepatitis C Infections Interferon Liver Liver cirrhosis Section 4: Clinical pharmacy services Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!